Toll‐like receptor 4 antagonist FP7 alleviates lipopolysaccharide‐induced septic shock via NF‐kB signaling pathway
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toll‐like receptor 4 antagonist FP7 alleviates lipopolysaccharide‐induced septic shock via NF‐kB signaling pathway
Authors
Keywords
-
Journal
Chemical Biology & Drug Design
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2021-02-27
DOI
10.1111/cbdd.13837
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of chemical modulation of toll-like receptor 4 in an animal model of ulcerative colitis
- (2020) Fabio Alessandro Facchini et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Anti-inflammatory effects of nobiletin on TLR4/TRIF/IRF3 and TLR9/IRF7 signaling pathways in prostate cancer cells
- (2020) Asuman Deveci Ozkan et al. IMMUNOPHARMACOLOGY AND IMMUNOTOXICOLOGY
- Toll-like Receptor 4-Independent Effects of Lipopolysaccharide Identified Using Longitudinal Serum Proteomics
- (2020) Erin Harberts et al. JOURNAL OF PROTEOME RESEARCH
- Sepsis inhibits tumor growth in mice with cancer through Toll-like receptor 4-associated enhanced Natural Killer cell activity
- (2019) Clara Vigneron et al. OncoImmunology
- The Role of RP105 in Cardiovascular Disease through Regulating TLR4 and PI3K Signaling Pathways
- (2019) Jian Yang et al. Current Medical Science
- ER-localized Hrd1 ubiquitinates and inactivates Usp15 to promote TLR4-induced inflammation during bacterial infection
- (2019) Yao Lu et al. Nature Microbiology
- Biochanin A attenuates myocardial ischemia/reperfusion injury through the TLR4/NF-κB/NLRP3 signaling pathway
- (2019) Yejun Bai et al. Acta Cirurgica Brasileira
- Immunobiology and application of toll-like receptor 4 agonists to augment host resistance to infection
- (2019) Antonio Hernandez et al. PHARMACOLOGICAL RESEARCH
- Structure–Activity Relationship in Monosaccharide-Based Toll-Like Receptor 4 (TLR4) Antagonists
- (2018) Fabio A. Facchini et al. JOURNAL OF MEDICINAL CHEMISTRY
- Heme Oxygenase-1 Protects the Liver from Septic Injury by Modulating TLR4-Mediated Mitochondrial Quality Control in Mice
- (2018) Jin-Sook Park et al. SHOCK
- The synthetic glycolipid-based TLR4 antagonist FP7 negatively regulates in vitro and in vivo haematopoietic and non-haematopoietic vascular TLR4 signalling
- (2018) Charys Palmer et al. Innate Immunity
- TLR4-based immunotherapeutics in cancer: a review of the achievements and shortcomings
- (2018) Maryam A. Shetab Boushehri et al. MOLECULAR PHARMACEUTICS
- TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells and protects mice from lethal influenza infection
- (2017) Laure Perrin-Cocon et al. Scientific Reports
- The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
- (2016) Mervyn Singer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Macrophage inflammasome mediates hyperhomocysteinemia-aggravated abdominal aortic aneurysm
- (2015) Weiliang Sun et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Modulation of CD14 and TLR4⋅MD-2 Activities by a Synthetic Lipid A Mimetic
- (2013) Roberto Cighetti et al. CHEMBIOCHEM
- Hyperhomocysteinemia Exaggerates Adventitial Inflammation and Angiotensin II−Induced Abdominal Aortic Aneurysm in Mice
- (2012) Ziyi Liu et al. CIRCULATION RESEARCH
- Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia
- (2010) Reut Fallach et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Evidence of a Specific Interaction between New Synthetic Antisepsis Agents and CD14
- (2009) Matteo Piazza et al. BIOCHEMISTRY
- TLR4 Polymorphisms and Ageing: Implications for the Pathophysiology of Age-Related Diseases
- (2009) Carmela Rita Balistreri et al. JOURNAL OF CLINICAL IMMUNOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now